Cellectis (CLLS) Competitor Comparison
We are evaluating the key criteria listed to compare Cellectis (CLLS) against its competitors in the Biotechnology industry.
Market Capitalization
228 / 368Gross Profits
84 / 278Total Revenue
152 / 300EBITDA
158 / 337Free Cashflow
208 / 352Quick Ratio
290 / 357Earnings per Share
147 / 359Dividend yield
0 / 6Total Cash
244 / 358Performance 3 years
249 / 368Performance 5 years
275 / 368Performance 10 years
295 / 368Linearity 3 years
249 / 368Linearity 5 years
230 / 368Linearity 10 years
195 / 367Total Rank
79 / 368Dividend Rank
81 / 368Valuation Rank
105 / 368Piotroski Rank
359 / 368Muliplier Rank
51 / 368Market Capitalization - CLLS ranking 228 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.